Close Menu

NEW YORK (360Dx) – Abbott reported Wednesday morning that its first quarter year-over-year sales in its Diagnostics business grew 59 percent on a reported basis, or 6 percent on an organic basis excluding current and prior-year results for its rapid diagnostics business purchased with Alere in October 2017.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.